Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
contract manufacturing
Pharma
Novartis reviews ties to China amid US biosecurity crackdown
Novartis is taking a proactive approach as it reviews its ties to Chinese contractors in the wake of the U.S. BIOSECURE Act, the company's CFO said.
Fraiser Kansteiner
Apr 23, 2024 11:07am
FTC to review Novo Holdings' Catalent buyout for 30 more days
Apr 8, 2024 11:58am
Merck KGaA's MilliporeSigma makes €300M pledge at new Korea site
Mar 21, 2024 1:22pm
IFF is selling off its pharma solutions business for $2.85B
Mar 19, 2024 10:40am
EuroAPI suspends 2024 guidance amid Italian production deficits
Mar 15, 2024 11:12am
Charles River to help Navega produce gene therapy candidate
Mar 14, 2024 9:50am